Backed by a fresh ₹500-crore capital expenditure plan and a ₹250-crore acquisition fund, the medtech firm is placing its bets ...

Learn more about whether Ocular Therapeutix, Inc. or Organon & Co. is a better investment based on AAII's A+ Investor grades, ...

Learn more about whether Liquidia Corporation or Organon & Co. is a better investment based on AAII's A+ Investor grades, ...

The company has a significant R&D arm in Ireland with numbers employed in R&D last year increasing from 224 to 270. Last year ...

Degrees Pharmaceuticals has entered into a clinical study agreement with the Icahn School of Medicine at Mount Sinai in the ...

The shares of this leading pharma company are in focus after the company secured a valuable contract in which it will take ...

With many PBMs under scrutiny, smaller startups that bill themselves as transparent are seeing interest from employers.

Unlike traditional pharmaceutical companies that own and market their products, CFAO Healthcare South Africa operates as a ...

The FDA has rejected vatiquinone, requesting that PTC run an additional study to prove the drug's efficacy prior to ...

Discover how India’s express logistics and parcel market is evolving with e-commerce growth, quick commerce, AI, and ...

The report "Dimethyl Carbonate Market by Application (Polycarbonate Synthesis, Battery Electrolyte, Solvents, Reagents), End-use Industry (Plastics ...

The MFN executive order introduces uncertainty in pharma pricing strategies, necessitating careful risk assessment and ...